Recent News

• 03.06.2025 - Delcath Systems Fourth Quarter 2024 Earnings Call
• 03.06.2025 - Delcath Systems Reports Fourth Quarter and Full Year 2024 Results
• 02.20.2025 - Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call
• 02.14.2025 - Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma
• 01.28.2025 - Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
• 01.13.2025 - Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
• 01.03.2025 - Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 12.30.2024 - Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises

Recent Filings

• 03.06.2025 - EX-99.1 EX-99.1
• 03.06.2025 - 8-K Current report
• 03.06.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.27.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership